{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T08:57:54Z","timestamp":1764061074949},"reference-count":59,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>It is well established that Intensive Care Units (ICUs) are a focal point in antimicrobial consumption with a major influence on the ecological consequences of antibiotic use. With the high prevalence and mortality of infections in critically ill patients, and the clinical challenges of treating patients with septic shock, the impact of real life clinical decisions made by intensivists becomes more significant. Both under- and over-treatment with unnecessarily broad spectrum antibiotics can lead to detrimental outcomes. Even though substantial progress has been made in developing rapid diagnostic tests that can help guide antibiotic use, there is still a time window when clinicians must decide the empiric antibiotic treatment with insufficient clinical data. The continuous streams of data available in the ICU environment make antimicrobial optimization an ongoing challenge for clinicians but at the same time can serve as the input for sophisticated models. In this review, we summarize the evidence to help guide antibiotic decision-making in the ICU. We focus on 1) deciding if to start antibiotics, 2) choosing the spectrum of the empiric agents to use, and 3) de-escalating the chosen empiric antibiotics. We provide a perspective on the role of machine learning and artificial intelligence models for clinical decision support systems that can be incorporated seamlessly into clinical practice in order to improve the antibiotic selection process and, more importantly, current and future patients' outcomes.<\/jats:p>","DOI":"10.1055\/s-0041-1741014","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T23:32:33Z","timestamp":1645054353000},"page":"141-149","source":"Crossref","is-referenced-by-count":4,"title":["Antibiotic Decision-Making in the ICU"],"prefix":"10.1055","volume":"43","author":[{"given":"Luis","family":"Parra-Rodriguez","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Cristina Vazquez","family":"Guillamet","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri"},{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"issue":"08","key":"ref1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.1995.03530080055041","article-title":"The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study","volume":"274","author":"J L Vincent","year":"1995","journal-title":"JAMA"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"e187571","DOI":"10.1001\/jamanetworkopen.2018.7571","article-title":"Prevalence, underlying causes, and preventability of sepsis-associated mortality in US acute care hospitals","volume":"2","author":"C Rhee","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.chest.2016.07.010","article-title":"Estimating ten-year trends in septic shock incidence and mortality in United States Academic Medical Centers using clinical data","volume":"151","author":"S S Kadri","year":"2017","journal-title":"Chest"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"A Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"A C Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"23","key":"ref7","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis","volume":"376","author":"C W Seymour","year":"2017","journal-title":"N Engl J Med"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"A Kumar","year":"2006","journal-title":"Crit Care Med"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0034-1398742","article-title":"Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy","volume":"36","author":"G Vazquez-Grande","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey","volume":"6","author":"A Versporten","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00134-019-05520-5","article-title":"Rationalizing antimicrobial therapy in the ICU: a narrative review","volume":"45","author":"J F Timsit","year":"2019","journal-title":"Intensive Care Med"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1128\/AAC.00627-10","article-title":"Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis","volume":"54","author":"M Paul","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1097\/CCM.0000000000000516","article-title":"Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock","volume":"42","author":"C Vazquez-Guillamet","year":"2014","journal-title":"Crit Care Med"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"e202899","DOI":"10.1001\/jamanetworkopen.2020.2899","article-title":"Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use","volume":"3","author":"C Rhee","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"12","key":"ref17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.7326\/M15-1754","article-title":"Importation, antibiotics, and clostridium difficile infection in veteran long-term care: a multilevel case-control study","volume":"164","author":"K A Brown","year":"2016","journal-title":"Ann Intern Med"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection","volume":"53","author":"V Stevens","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13054-016-1266-9","article-title":"Diagnosing sepsis is subjective and highly variable: a survey of intensivists using case vignettes","volume":"20","author":"C Rhee","year":"2016","journal-title":"Crit Care"},{"issue":"17","key":"ref20","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMoa1415236","article-title":"Systemic inflammatory response syndrome criteria in defining severe sepsis","volume":"372","author":"K M Kaukonen","year":"2015","journal-title":"N Engl J Med"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13054-015-1035-1","article-title":"Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study","volume":"19","author":"P M Klein Klouwenberg","year":"2015","journal-title":"Crit Care"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmi.2019.07.007","article-title":"When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit","volume":"26","author":"K J Denny","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1517\/14740338.2016.1164690","article-title":"The use and risks of antibiotics in critically ill patients","volume":"15","author":"K J Denny","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S1473-3099(12)70151-2","article-title":"Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study","volume":"12","author":"T Hranjec","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"S 03","key":"ref25","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1093\/cid\/ciu547","article-title":"Review of rapid diagnostic tests used by antimicrobial stewardship programs","volume":"59","author":"K A Bauer","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1513\/AnnalsATS.201902-162OC","article-title":"Potential impact of hospital-acquired pneumonia guidelines on empiric antibiotics. an evaluation of 113 veterans affairs medical centers","volume":"16","author":"A D Bostwick","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"08","key":"ref27","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/529440","article-title":"At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia","volume":"46","author":"N Daneman","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41467-021-21088-5","article-title":"A game theoretic approach reveals that discretizing clinical information can reduce antibiotic misuse","volume":"12","author":"M Diamant","year":"2021","journal-title":"Nat Commun"},{"key":"ref29","volume-title":"Computer-Based Medical Consultation. MYCIN","author":"E H Shortliffe","year":"1976"},{"issue":"03","key":"ref30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cmi.2019.07.002","article-title":"Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection","volume":"26","author":"D Viasus","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"06","key":"ref31","doi-asserted-by":"crossref","first-page":"e0199531","DOI":"10.1371\/journal.pone.0199531","article-title":"Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance","volume":"13","author":"C Garcia-Vidal","year":"2018","journal-title":"PLoS One"},{"issue":"07","key":"ref32","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/cid\/ciw425","article-title":"A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum \u03b2-lactamase-producing organism","volume":"63","author":"K E Goodman","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/cid\/cix612","article-title":"Predicting resistance to piperacillin-tazobactam, cefepime and meropenem in septic patients with bloodstream infection due to gram-negative bacteria","volume":"65","author":"M C Vazquez-Guillamet","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"108.e1","DOI":"10.1016\/j.cmi.2018.03.029","article-title":"Decision-support models for empiric antibiotic selection in gram-negative bloodstream infections","volume":"25","author":"D R MacFadden","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cmi.2019.09.009","article-title":"Machine learning for clinical decision support in infectious diseases: a narrative review of current applications","volume":"26","author":"N Peiffer-Smadja","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/QCO.0000000000000406","article-title":"Machine learning: novel bioinformatics approaches for combating antimicrobial resistance","volume":"30","author":"N Macesic","year":"2017","journal-title":"Curr Opin Infect Dis"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.2196\/medinform.3445","article-title":"From data to optimal decision making: a data-driven, probabilistic machine learning approach to decision support for patients with sepsis","volume":"3","author":"A Tsoukalas","year":"2015","journal-title":"JMIR Med Inform"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"R F Wolff","year":"2019","journal-title":"Ann Intern Med"},{"key":"ref40","volume-title":"Clinical Epidemiology: Principles, Methods, and Applications for Clinical Research","author":"D E Grobbee","year":"2009"},{"issue":"02","key":"ref41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1148\/radiology.167.2.3357976","article-title":"Assessment of radiologic tests: control of bias and other design considerations","volume":"167","author":"C B Begg","year":"1988","journal-title":"Radiology"},{"issue":"05","key":"ref42","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00001648-199209000-00009","article-title":"Dichotomizing continuous outcome variables: dependence of the magnitude of association and statistical power on the cutpoint","volume":"3","author":"D R Ragland","year":"1992","journal-title":"Epidemiology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2288-14-137","article-title":"Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints","volume":"14","author":"T van der Ploeg","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"b606","DOI":"10.1136\/bmj.b606","article-title":"Prognosis and prognostic research: application and impact of prognostic models in clinical practice","volume":"338","author":"K G Moons","year":"2009","journal-title":"BMJ"},{"issue":"04","key":"ref45","doi-asserted-by":"crossref","first-page":"e0215480","DOI":"10.1371\/journal.pone.0215480","article-title":"Medical prescribing and antibiotic resistance: a game-theoretic analysis of a potentially catastrophic social dilemma","volume":"14","author":"A M Colman","year":"2019","journal-title":"PLoS One"},{"issue":"09","key":"ref46","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/cid\/ciy375","article-title":"Acinetobacter pneumonia: improving outcomes with early identification and appropriate therapy","volume":"67","author":"C Vazquez Guillamet","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"09","key":"ref47","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/cid\/cit498","article-title":"Impact of rapid organism identification via matrix-assisted laser desorption\/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia","volume":"57","author":"A M Huang","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cid\/ciw649","article-title":"The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis","volume":"64","author":"T T Timbrook","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref49","first-page":"CD007934","article-title":"De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock","volume":"12","author":"B N Gomes Silva","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00134-013-3077-7","article-title":"De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock","volume":"40","author":"J Garnacho-Montero","year":"2014","journal-title":"Intensive Care Med"},{"issue":"07","key":"ref51","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1007\/s00134-020-06111-5","article-title":"Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study","volume":"46","author":"L De Bus","year":"2020","journal-title":"Intensive Care Med"},{"issue":"07","key":"ref52","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial","volume":"16","author":"E de Jong","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"01","key":"ref53","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13613-017-0338-6","article-title":"Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis","volume":"7","author":"H B Huang","year":"2017","journal-title":"Ann Intensive Care"},{"issue":"24","key":"ref54","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1207290","article-title":"Targeted versus universal decolonization to prevent ICU infection","volume":"368","author":"S S Huang","year":"2013","journal-title":"N Engl J Med"},{"issue":"04","key":"ref55","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1017\/ice.2017.4","article-title":"The effect of universal decolonization with screening in critical care to reduce MRSA across an entire hospital","volume":"38","author":"C W Bradley","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"S 03","key":"ref56","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1086\/677819","article-title":"Cost savings of universal decolonization to prevent intensive care unit infection: implications of the REDUCE MRSA trial","volume":"35","author":"S S Huang","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"06","key":"ref57","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1086\/422997","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection","volume":"39","author":"K A Davis","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.01805-13","article-title":"Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia","volume":"58","author":"B Dangerfield","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/cid\/ciz974","article-title":"Determining the utility of methicillin-resistant Staphylococcus aureus nares screening in antimicrobial stewardship","volume":"71","author":"K A Mergenhagen","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1097\/CCM.0b013e3181eeda3f","article-title":"Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment","volume":"38","author":"K V Sarikonda","year":"2010","journal-title":"Crit Care Med"},{"issue":"03","key":"ref61","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/cid\/ciw300","article-title":"Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics, and outcomes","volume":"63","author":"W H Self","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref62","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S1473-3099(16)30267-5","article-title":"Global initiative for methicillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study","volume":"16","author":"S Aliberti","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"08","key":"ref63","doi-asserted-by":"crossref","first-page":"e0183062","DOI":"10.1371\/journal.pone.0183062","article-title":"The effectiveness of computerised decision support on antibiotic use in hospitals: a systematic review","volume":"12","author":"C E Curtis","year":"2017","journal-title":"PLoS One"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1741014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T23:48:26Z","timestamp":1645055306000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1741014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":59,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2022,2,16]]},"published-print":{"date-parts":[[2022,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1741014","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}